Boston Scientific (BSX) shares fell 2.3% after confirming it will miss Q3 and full-year 2026 guidance due to August cyberattack impact on operations.
Original Image Link
Source:blockonomi.com
Original Image Link
Source:blockonomi.com
Posted: 2026-09-08 05:30:00








